SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 125 filers reported holding SERES THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,542,858 | +33.9% | 2,749,100 | +169.4% | 0.02% | +26.7% |
| Q2 2023 | $4,887,716 | +194.4% | 1,020,400 | +248.5% | 0.02% | +200.0% |
| Q1 2023 | $1,660,176 | -57.6% | 292,800 | -58.1% | 0.01% | -61.5% |
| Q4 2022 | $3,917,760 | -35.0% | 699,600 | -25.5% | 0.01% | -45.8% |
| Q3 2022 | $6,031,000 | +424.9% | 939,429 | +180.4% | 0.02% | +380.0% |
| Q2 2022 | $1,149,000 | -94.3% | 335,000 | -65.6% | 0.01% | -94.7% |
| Q1 2021 | $20,068,000 | +676.9% | 974,671 | +824.3% | 0.09% | +623.1% |
| Q4 2020 | $2,583,000 | -45.2% | 105,446 | -36.6% | 0.01% | -45.8% |
| Q3 2020 | $4,710,000 | – | 166,388 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |